76 related articles for article (PubMed ID: 8557140)
1. In situ and invasive cervical carcinoma in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
Fertil Steril; 1996 Jan; 65(1):19-22. PubMed ID: 8557140
[TBL] [Abstract][Full Text] [Related]
2. Risk of breast cancer in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
Gynecol Oncol; 1996 Jan; 60(1):3-7. PubMed ID: 8557223
[TBL] [Abstract][Full Text] [Related]
3. Risk of cutaneous melanoma in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
Melanoma Res; 1995 Apr; 5(2):123-7. PubMed ID: 7620340
[TBL] [Abstract][Full Text] [Related]
4. Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.
Lerner-Geva L; Keinan-Boker L; Blumstein T; Boyko V; Olmar L; Mashiach S; Rabinovici J; Potashnik G; Lunenfeld E; Schenker JG; Shushan A; Fishman A; Cohen I; Vagman I; Lunenfeld B
Breast Cancer Res Treat; 2006 Nov; 100(2):201-12. PubMed ID: 16685587
[TBL] [Abstract][Full Text] [Related]
5. Ovarian tumors in a cohort of infertile women.
Rossing MA; Daling JR; Weiss NS; Moore DE; Self SG
N Engl J Med; 1994 Sep; 331(12):771-6. PubMed ID: 8065405
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer incidence after hormonal infertility treatment in Sweden: a cohort study.
Orgéas CC; Sanner K; Hall P; Conner P; Holte J; Nilsson SJ; Sundfeldt K; Persson I; Chia KS; Wedren S; Dickman PW; Czene K
Am J Obstet Gynecol; 2009 Jan; 200(1):72.e1-7. PubMed ID: 19121659
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and standardized incidence rates of preclinical cervical pathology among 1,061 women sterilized with transcervical quinacrine hydrochloride pellets.
Dabancens A; Sokal DC; Pruyas M; Rivera M; Zipper J
Fertil Steril; 1995 Aug; 64(2):444-6. PubMed ID: 7615128
[TBL] [Abstract][Full Text] [Related]
8. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs.
Althuis MD; Scoccia B; Lamb EJ; Moghissi KS; Westhoff CL; Mabie JE; Brinton LA
Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 1):668-74. PubMed ID: 16150258
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer risk after the use of ovulation-stimulating drugs.
Brinton LA; Lamb EJ; Moghissi KS; Scoccia B; Althuis MD; Mabie JE; Westhoff CL
Obstet Gynecol; 2004 Jun; 103(6):1194-203. PubMed ID: 15172852
[TBL] [Abstract][Full Text] [Related]
10. Uterine cancer after use of clomiphene citrate to induce ovulation.
Althuis MD; Moghissi KS; Westhoff CL; Scoccia B; Lamb EJ; Lubin JH; Brinton LA
Am J Epidemiol; 2005 Apr; 161(7):607-15. PubMed ID: 15781949
[TBL] [Abstract][Full Text] [Related]
11. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
[TBL] [Abstract][Full Text] [Related]
12. Ovarian epithelial neoplasia after hormonal infertility treatment: long-term follow-up of a historical cohort in Sweden.
Sanner K; Conner P; Bergfeldt K; Dickman P; Sundfeldt K; Bergh T; Hagenfeldt K; Janson PO; Nilsson S; Persson I
Fertil Steril; 2009 Apr; 91(4):1152-8. PubMed ID: 18371964
[TBL] [Abstract][Full Text] [Related]
13. Thyroid cancer risk in women with infertility and association with fertility medications in Taiwan.
Ding DC; Chen W; Wang JH; Lin SZ; Sung FC
Cancer; 2019 May; 125(10):1701-1708. PubMed ID: 30645760
[TBL] [Abstract][Full Text] [Related]
14. Infertility treatment and the risk of cancer.
Storeng R; Vangen S; Omland AK; Oldereid NB
Tidsskr Nor Laegeforen; 2012 Nov; 132(22):2494-9. PubMed ID: 23338030
[TBL] [Abstract][Full Text] [Related]
15. Use of fertility drugs and risk of uterine cancer: results from a large Danish population-based cohort study.
Jensen A; Sharif H; Kjaer SK
Am J Epidemiol; 2009 Dec; 170(11):1408-14. PubMed ID: 19884127
[TBL] [Abstract][Full Text] [Related]
16. Ovulation induction and risk of endometrial cancer: a pilot study.
Benshushan A; Paltiel O; Brzezinski A; Tanos V; Barchana M; Shoshani O; Gordon L; Tsur L; Schenker JG
Eur J Obstet Gynecol Reprod Biol; 2001 Sep; 98(1):53-7. PubMed ID: 11516800
[TBL] [Abstract][Full Text] [Related]
17. Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysis.
Kashyap S; Moher D; Fung MF; Rosenwaks Z
Obstet Gynecol; 2004 Apr; 103(4):785-94. PubMed ID: 15051576
[TBL] [Abstract][Full Text] [Related]
18. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study.
Hannibal CG; Jensen A; Sharif H; Kjaer SK
Hum Reprod; 2008 Feb; 23(2):451-6. PubMed ID: 18065402
[TBL] [Abstract][Full Text] [Related]
19. Fertility drug use and risk of ovarian tumors: a debated clinical challenge.
Gadducci A; Guerrieri ME; Genazzani AR
Gynecol Endocrinol; 2013 Jan; 29(1):30-5. PubMed ID: 22946709
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment and co-administration of oral anti-diabetic agent with clomiphene citrate or rFSH for ovulation induction in clomiphene-citrate-resistant polycystic ovary syndrome.
Begum MR; Akhter S; Ehsan M; Begum MS; Khan F
J Obstet Gynaecol Res; 2013 May; 39(5):966-73. PubMed ID: 23379651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]